viimane versioon :
08/11/2024
Infostab
ingredientide nimekiri
nimekiri
Sobivus otsing
Y-liini sobivuse tabel
Viited
uurimisrühmad
valistab
plakat
Sidemed
sponsorid
Autor
Kasutusjuhend
ajakiri
Viited 3976
tüüp :
ajaleht
interneti link :
https://doi.org/10.2146/ajhp170111
898Ko
uurimisrühmad :
Marseille - La Timone University Teaching Hospital, Pharmacy Department
Autor :
Du Repaire T, Vigne P, Guedon A, Gauthier-Villano L, Bertault Peres P, Pourroy B.
pealkiri :
Visual compatibility of blinatumomab with selected co-administrated drugs during simulated Y-site administration.
publikatsioon :
Am J Health-Syst Pharm ; 74,16 : 1217-1218 2017
Tõendite tase :
füüsikaline stabiilsus :
Keemiline püsivus :
Muud meetodid :
Kommentaarid :
ingredientide nimekiri
Alizapride hydrochloride
0.5 mg/ml
+
Blinatumomab
0.125 & 0.375 µg/ml
+
Amphotericin B liposomale
1 mg/ml
+
Blinatumomab
0.125 & 0.375 µg/ml
+
Blinatumomab
0.125 & 0.375 µg/ml
+
Alizapride hydrochloride
0.5 mg/ml
+
0.125 & 0.375 µg/ml
+
Amphotericin B liposomale
1 mg/ml
+
0.125 & 0.375 µg/ml
+
Caffeine citrate
25 mg/ml
+
0.125 & 0.375 µg/ml
+
Caspofungin acetate
0.20 mg/ml
+
0.125 & 0.375 µg/ml
+
Ceftazidime
34.5 mg/ml
+
0.125 & 0.375 µg/ml
+
Ceftriaxone disodium
50 mg/ml
+
0.125 & 0.375 µg/ml
+
Ciprofloxacin lactate
2 mg/ml
+
0.125 & 0.375 µg/ml
+
Clonazepam
0.02 mg/ml
+
0.125 & 0.375 µg/ml
+
Cloxacillin sodium
8.6 mg/ml
+
0.125 & 0.375 µg/ml
+
Co-trimoxazole
3.2 mg/ml
+
0.125 & 0.375 µg/ml
+
Daptomycin
6.1 mg/ml
+
0.125 & 0.375 µg/ml
+
Dexamethasone sodium phosphate
0.19 mg/ml
+
0.125 & 0.375 µg/ml
+
Furosemide
2.9 mg/ml
+
0.125 & 0.375 µg/ml
+
Heparin sodium
192.3 UI/ml
+
0.125 & 0.375 µg/ml
+
Human albumin
100 mg/ml
+
0.125 & 0.375 µg/ml
+
Human albumin
100 mg/ml
+
0.125 & 0.375 µg/ml
+
Hydrocortisone sodium succinate
0.98 mg/ml
+
0.125 & 0.375 µg/ml
+
Hydroxyzine dihydrochloride
0.4 mg/ml
+
0.125 & 0.375 µg/ml
+
Imipenem - cilastatin sodium
5 mg/ml
+
0.125 & 0.375 µg/ml
+
Meropenem
8.3 mg/ml
+
0.125 & 0.375 µg/ml
+
Methylprednisolone sodium succinate
5 mg/ml
+
0.125 & 0.375 µg/ml
+
Metronidazole
2.5 mg/ml
+
0.125 & 0.375 µg/ml
+
Midazolam hydrochloride
1 mg/ml
+
0.125 & 0.375 µg/ml
+
Morphine hydrochloride
1 mg/ml
+
0.125 & 0.375 µg/ml
+
Nalbuphine hydrochloride
1 mg/ml
+
0.125 & 0.375 µg/ml
+
Naloxone hydrochloride
0.2 mg/ml
+
0.125 & 0.375 µg/ml
+
Nefopam
2.5 mg/ml
+
0.125 & 0.375 µg/ml
+
Omeprazole sodium
0.4 mg/ml
+
0.125 & 0.375 µg/ml
+
Ondansetron hydrochloride
0.2 mg/ml
+
0.125 & 0.375 µg/ml
+
Pantoprazole sodium
0.8 mg/ml
+
0.125 & 0.375 µg/ml
+
Paracetamol
10 mg/ml
+
0.125 & 0.375 µg/ml
+
Phloroglucinol
5 mg/ml
+
0.125 & 0.375 µg/ml
+
Potassium chloride
0.3 mEq/l
+
0.125 & 0.375 µg/ml
+
Rasburicase
0.15 mg/ml
+
0.125 & 0.375 µg/ml
+
Teicoplanine
4 mg/ml
+
0.125 & 0.375 µg/ml
+
Tranexamic acid
100 mg/ml
+
0.125 & 0.375 µg/ml
+
Vancomycin hydrochloride
2 mg/ml
+
0.125 & 0.375 µg/ml
+
Caffeine citrate
25 mg/ml
+
Blinatumomab
0.125 & 0.375 µg/ml
+
Caspofungin acetate
0.20 mg/ml
+
Blinatumomab
0.125 & 0.375 µg/ml
+
Ceftazidime
34.5 mg/ml
+
Blinatumomab
0.125 & 0.375 µg/ml
+
Ceftriaxone disodium
50 mg/ml
+
Blinatumomab
0.125 & 0.375 µg/ml
+
Ciprofloxacin lactate
2 mg/ml
+
Blinatumomab
0.125 & 0.375 µg/ml
+
Clonazepam
0.02 mg/ml
+
Blinatumomab
0.125 & 0.375 µg/ml
+
Cloxacillin sodium
8.6 mg/ml
+
Blinatumomab
0.125 & 0.375 µg/ml
+
Co-trimoxazole
3.2 mg/ml
+
Blinatumomab
0.125 & 0.375 µg/ml
+
Daptomycin
6.1 mg/ml
+
Blinatumomab
0.125 & 0.375 µg/ml
+
Dexamethasone sodium phosphate
0.19 mg/ml
+
Blinatumomab
0.125 & 0.375 µg/ml
+
Furosemide
2.9 mg/ml
+
Blinatumomab
0.125 & 0.375 µg/ml
+
Heparin sodium
192.3 UI/ml
+
Blinatumomab
0.125 & 0.375 µg/ml
+
Human albumin
100 mg/ml
+
Blinatumomab
0.125 & 0.375 µg/ml
+
100 mg/ml
+
Blinatumomab
0.125 & 0.375 µg/ml
+
Hydrocortisone sodium succinate
0.98 mg/ml
+
Blinatumomab
0.125 & 0.375 µg/ml
+
Hydroxyzine dihydrochloride
0.4 mg/ml
+
Blinatumomab
0.125 & 0.375 µg/ml
+
Imipenem - cilastatin sodium
5 mg/ml
+
Blinatumomab
0.125 & 0.375 µg/ml
+
Meropenem
8.3 mg/ml
+
Blinatumomab
0.125 & 0.375 µg/ml
+
Methylprednisolone sodium succinate
5 mg/ml
+
Blinatumomab
0.125 & 0.375 µg/ml
+
Metronidazole
2.5 mg/ml
+
Blinatumomab
0.125 & 0.375 µg/ml
+
Midazolam hydrochloride
1 mg/ml
+
Blinatumomab
0.125 & 0.375 µg/ml
+
Morphine hydrochloride
1 mg/ml
+
Blinatumomab
0.125 & 0.375 µg/ml
+
Nalbuphine hydrochloride
1 mg/ml
+
Blinatumomab
0.125 & 0.375 µg/ml
+
Naloxone hydrochloride
0.2 mg/ml
+
Blinatumomab
0.125 & 0.375 µg/ml
+
Nefopam
2.5 mg/ml
+
Blinatumomab
0.125 & 0.375 µg/ml
+
Omeprazole sodium
0.4 mg/ml
+
Blinatumomab
0.125 & 0.375 µg/ml
+
Ondansetron hydrochloride
0.2 mg/ml
+
Blinatumomab
0.125 & 0.375 µg/ml
+
Pantoprazole sodium
0.8 mg/ml
+
Blinatumomab
0.125 & 0.375 µg/ml
+
Paracetamol
10 mg/ml
+
Blinatumomab
0.125 & 0.375 µg/ml
+
Phloroglucinol
5 mg/ml
+
Blinatumomab
0.125 & 0.375 µg/ml
+
Potassium chloride
0.3 mEq/l
+
Blinatumomab
0.125 & 0.375 µg/ml
+
Rasburicase
0.15 mg/ml
+
Blinatumomab
0.125 & 0.375 µg/ml
+
Teicoplanine
4 mg/ml
+
Blinatumomab
0.125 & 0.375 µg/ml
+
Tranexamic acid
100 mg/ml
+
Blinatumomab
0.125 & 0.375 µg/ml
+
Vancomycin hydrochloride
2 mg/ml
+
Blinatumomab
0.125 & 0.375 µg/ml
+
Mentions Légales